Literature DB >> 21518761

Inflammatory cytokines determine the susceptibility of human CD8 T cells to Fas-mediated activation-induced cell death through modulation of FasL and c-FLIP(S) expression.

Anna von Rossum1, Randall Krall, Nichole K Escalante, Jonathan C Choy.   

Abstract

The nature of inflammatory signals determines the outcome of T cell responses. However, little is known about how inflammatory cytokines provided to human CD8 T cells during activation affects their susceptibility to post-activation cell death. We have examined and compared the effects of the inflammatory cytokine IL-12, as well as the combination of IL-1, IL-6, and IL-23 (IL-1/6/23) on the susceptibility of primary human CD8 T cells to post-activation cell death. Human CD8 T cells activated in the presence of IL-1/6/23 underwent significantly less cell death after activation as compared with those activated in IL-12. This was due to reduced susceptibility to Fas-mediated activation-induced cell death (AICD). Mechanistically, the reduced level of cell death in CD8 T cells activated in IL-1/6/23 was a result of a low level of FasL expression and high level of c-FLIP(S) expression. When the effect of IL-1, IL-6, and IL-23 individually was examined, IL-1 or IL-6 alone was sufficient to inhibit CD8 T cell death that occurs after activation in IL-12. IL-1, but not IL-6, inhibited expression of FasL, whereas IL-6, but not IL-1, increased c-FLIP(S) expression. Our findings show that the presence of IL-1 and/or IL-6 during activation of human CD8 T cells attenuates Fas-mediated AICD, whereas IL-12 increases the susceptibility of activated CD8 T cells to this form of cell death.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21518761      PMCID: PMC3122175          DOI: 10.1074/jbc.M110.197657

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  IL-12 receptor. II. Distribution and regulation of receptor expression.

Authors:  B B Desai; P M Quinn; A G Wolitzky; P K Mongini; R Chizzonite; M K Gately
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

2.  Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis.

Authors:  J B Crusius; A S Peña; B W Van Oosten; G Bioque; A Garcia; C D Dijkstra; C H Polman
Journal:  Lancet       Date:  1995-10-07       Impact factor: 79.321

3.  Alloantigen-dependent endothelial phenotype and lymphokine mRNA expression in rejecting murine cardiac allografts.

Authors:  C J Morgan; R P Pelletier; C J Hernandez; D L Teske; E Huang; R Ohye; C G Orosz; R M Ferguson
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

4.  A murine model of inducible, cardiac-specific deletion of STAT3: its use to determine the role of STAT3 in the upregulation of cardioprotective proteins by ischemic preconditioning.

Authors:  Roberto Bolli; Adam B Stein; Yiru Guo; Ou-Li Wang; Gregg Rokosh; Buddhadeb Dawn; Jeffery D Molkentin; Santosh K Sanganalmath; Yanqing Zhu; Yu-Ting Xuan
Journal:  J Mol Cell Cardiol       Date:  2011-01-09       Impact factor: 5.000

5.  Alloreactive murine CD8+ T cell clones secrete the Th1 pattern of cytokines.

Authors:  T A Fong; T R Mosmann
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

6.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.

Authors:  R Watanabe-Fukunaga; C I Brannan; N G Copeland; N A Jenkins; S Nagata
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

7.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

Authors:  T Takahashi; M Tanaka; C I Brannan; N A Jenkins; N G Copeland; T Suda; S Nagata
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

8.  Interleukin-6 is elevated in plasma in multiple sclerosis.

Authors:  K Frei; S Fredrikson; A Fontana; H Link
Journal:  J Neuroimmunol       Date:  1991-02       Impact factor: 3.478

9.  The inhibitor cytokine interleukin-1 receptor antagonist synergistically augments cyclosporine immunosuppression in a rat cardiac allograft model.

Authors:  M Shiraishi; M Csete; C Yasunaga; S V McDiarmid; J L Vannice; R W Busuttil; A Shaked
Journal:  J Surg Res       Date:  1995-05       Impact factor: 2.192

10.  Fas ligand mediates activation-induced cell death in human T lymphocytes.

Authors:  M R Alderson; T W Tough; T Davis-Smith; S Braddy; B Falk; K A Schooley; R G Goodwin; C A Smith; F Ramsdell; D H Lynch
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more
  9 in total

1.  Potentiating functional antigen-specific CD8⁺ T cell immunity by a novel PD1 isoform-based fusion DNA vaccine.

Authors:  Jingying Zhou; Allen Kl Cheung; Henggui Liu; Zhiwu Tan; Xian Tang; Yuanxi Kang; Yanhua Du; Haibo Wang; Li Liu; Zhiwei Chen
Journal:  Mol Ther       Date:  2013-04-16       Impact factor: 11.454

2.  Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease.

Authors:  Schafiq Nabhani; Sebastian Ginzel; Hagit Miskin; Shoshana Revel-Vilk; Dan Harlev; Bernhard Fleckenstein; Andrea Hönscheid; Prasad T Oommen; Michaela Kuhlen; Ralf Thiele; Hans-Jürgen Laws; Arndt Borkhardt; Polina Stepensky; Ute Fischer
Journal:  Haematologica       Date:  2015-06-25       Impact factor: 9.941

3.  CD8+ T Cells Contribute to the Development of Coronary Arteritis in the Lactobacillus casei Cell Wall Extract-Induced Murine Model of Kawasaki Disease.

Authors:  Magali Noval Rivas; Youngho Lee; Daiko Wakita; Norika Chiba; Jargalsaikhan Dagvadorj; Kenichi Shimada; Shuang Chen; Michael C Fishbein; Thomas J A Lehman; Timothy R Crother; Moshe Arditi
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

4.  Positive feedback regulation of human inducible nitric-oxide synthase expression by Ras protein S-nitrosylation.

Authors:  Martin Lee; Jonathan C Choy
Journal:  J Biol Chem       Date:  2013-04-18       Impact factor: 5.157

5.  Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections.

Authors:  Ulrike Gerdemann; Jacqueline M Keirnan; Usha L Katari; Ryu Yanagisawa; Anne S Christin; Leslie E Huye; Serena K Perna; Sravya Ennamuri; Stephen Gottschalk; Malcolm K Brenner; Helen E Heslop; Cliona M Rooney; Ann M Leen
Journal:  Mol Ther       Date:  2012-07-17       Impact factor: 11.454

Review 6.  Overcoming tumor immune evasion with an unique arbovirus.

Authors:  Bruce Lyday; Tony Chen; Santosh Kesari; Boris Minev
Journal:  J Transl Med       Date:  2015-01-16       Impact factor: 5.531

7.  The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis.

Authors:  Maria A Stacey; Simon Clare; Mathew Clement; Morgan Marsden; Juneid Abdul-Karim; Leanne Kane; Katherine Harcourt; Cordelia Brandt; Ceri A Fielding; Sarah E Smith; Rachael S Wash; Silvia Gimeno Brias; Gabrielle Stack; George Notley; Emma L Cambridge; Christopher Isherwood; Anneliese O Speak; Zoë Johnson; Walter Ferlin; Simon A Jones; Paul Kellam; Ian R Humphreys
Journal:  J Clin Invest       Date:  2017-02-27       Impact factor: 14.808

8.  Differences in plasma cytokine levels between elite kayakers and nonathletes.

Authors:  G F Borges; L Rama; S Pedreiro; F Alves; A Santos; A Massart; A Paiva; A M Teixeira
Journal:  Biomed Res Int       Date:  2013-05-27       Impact factor: 3.411

9.  IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells.

Authors:  Shlomo Z Ben-Sasson; Alison Hogg; Jane Hu-Li; Paul Wingfield; Xi Chen; Michelle Crank; Stephane Caucheteux; Maya Ratner-Hurevich; Jay A Berzofsky; Ran Nir-Paz; William E Paul
Journal:  J Exp Med       Date:  2013-03-04       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.